The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Immunovant Inc shares valued at $474,861 were purchased by WILLIAM MACIAS on Jun 25 ’25. At $15.83 per share, WILLIAM MACIAS acquired 30,000 shares.
Also, WILLIAM MACIAS purchased 50,000 shares, netting a total of over 778,490 in proceeds.
Before that, WILLIAM MACIAS had added 80,000 shares to its account. In a trade valued at $1,248,616, the Officer bought Immunovant Inc shares for $15.61 each.
As published in their initiating research note from Jefferies on March 03, 2025, Immunovant Inc [IMVT] has been a Hold and the price target has been revised to $20. Analysts at Wolfe Research downgraded the stock from ‘”an Outperform”‘ to ‘”a Peer perform”‘ outlook in a report released in early January. Earlier on October 09, 2024, Oppenheimer resumed its rating. Their recommendation was “an Outperform” for IMVT stock.
Analyzing IMVT Stock Performance
On last trading session,, Immunovant Inc [NASDAQ: IMVT] rose 2.37% to $17.29. The stock’s lowest price that day was $16.97, but it reached a high of $17.52 in the same session. During the last five days, there has been a surge of approximately 7.06%. Over the course of the year, Immunovant Inc shares have dropped approximately -35.69%. Shares of the company reached a 52-week high of $25.79 on 01/02/25 and a 52-week low of $12.72 on 04/09/25.
Support And Resistance Levels for Immunovant Inc (IMVT)
According to the 24-hour chart, there is a support level at 17.00, which, if violated, would cause prices to drop to 16.71. In the upper region, resistance lies at 17.55. The next price resistance is at 17.81. RSI (Relative Strength Index) is 62.75 on the 14-day chart, showing neutral technical sentiment.
Is Immunovant Inc subject to short interest?
Stocks of Immunovant Inc saw a sharp steep in short interest on 2025-06-13 dropping by -1.48 million shares to 19.92 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 21.4 million shares. A decline of -7.43% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 15.71 of the overall float, the days-to-cover ratio (short ratio) decline to 15.71.
Which companies own the most shares of Immunovant Inc (IMVT)?
In terms of Immunovant Inc share price expectations, FactSet research, analysts set an average price target of 49 in the next 12 months, up nearly 190.11% from the previous closing price of $16.89. Analysts anticipate Immunovant Inc stock to reach 57 by 2025, with the lowest price target being 5. In spite of this, 20 analysts ranked Immunovant Inc stock as Buy at the end of 2025. On March 28, 2024, Oppenheimer assigned a price target of “an Outperform” to the stock and initiated coverage with a $50.
